UM  > 中華醫藥研究院
Pharmaceutical innovation network: Global patterns and the role of China
Pengpeng Li; Huiheng Lin; Yuanjia Hu
Source PublicationInnovation Value Chain of Chinese Pharmaceuticals
Author of SourceYitao Wang, Yuanjia Hu, Albert Wai-Kit Chan
Publication PlaceWhitestone, New York
PublisherUnited States-China Intellectual Property Institute Inc.

In recent decades, the increasing R&D investment in the pharmaceutical sector of emerging economies has been shaping the novel global pharmaceutical innovation network. This study aims to investigate the dynamics of the innovation landscape in the pharmaceutical sector and identify the changing role of different countries via (1) collaborative innovation network composed of co-inventorship on new drug patents as well as (2) evaluating the role of China within the global network. The Social Network Analysis approach was utilized to analyze the information of inventors in USTPO-granted patents of new drugs and model the structure of pharmaceutical collaborative innovation network. The findings show that R&D collaborations have gained substantial momentum in pharmaceutical innovation, especially during 2011-2015. During four of the “five-year” development plans set and implemented by China government, a remarkable increase has been identified in the international collaborative innovation activities and a large shift of the innovation network landscape took place, particularly during year 2006-2010 and 2011-2015. The United States, United Kingdom and Germany collectively form a dominant cluster in the network, which was demonstrated by various network centrality measures. Additionally, the dominance of the United States was weakened during 2006-2015. Instead, the European countries were rising in pharmaceutical co-innovation, partly due to reinforcement of intra-European countries. Meanwhile, the young member China, with skyrocketing R&D investment, failed to seize the chance to cut a figure. Last but not least, we propose that friendly policy environment is also needed for enhancing pharmaceutical innovation.

KeywordPharmaceutical Innovation Drug Patents Network Analysis
Fulltext Access
Document TypeBook chapter
CollectionInstitute of Chinese Medical Sciences
AffiliationState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau SAR, China
First Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Pengpeng Li,Huiheng Lin,Yuanjia Hu. Pharmaceutical innovation network: Global patterns and the role of China. Whitestone, New York:United States-China Intellectual Property Institute Inc.,2017:259-281.
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Pengpeng Li]'s Articles
[Huiheng Lin]'s Articles
[Yuanjia Hu]'s Articles
Baidu academic
Similar articles in Baidu academic
[Pengpeng Li]'s Articles
[Huiheng Lin]'s Articles
[Yuanjia Hu]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Pengpeng Li]'s Articles
[Huiheng Lin]'s Articles
[Yuanjia Hu]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.